Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2012 / Cilt: 18 - Sayı: 5

Yanık yarası tedavisinde topikal çinko oksit ile gümüş sülfadiazinin karşılaştırılması: Deneysel çalışma

Comparison of topical zinc oxide and silver sulfadiazine in burn wounds: an experimental study

Pages
376–383
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION In this experimental burn study, zinc oxide was more effective than silver sulfadiazine in terms of epithelization, dermis maturation and scar formation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND We aimed to compare the effects of topical zinc oxide and topical silver sulfadiazine in the treatment of partial-thickness burn wounds.
📊
Key Findings & Data:METHODS The study was conducted with 20 New Zealand rabbits, and burn wounds were created by a brass probe.
💡
Conclusion & Impact:CONCLUSION In this experimental burn study, zinc oxide was more effective than silver sulfadiazine in terms of epithelization, dermis maturation and scar formation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND We aimed to compare the effects of topical zinc oxide and topical silver sulfadiazine in the treatment of partial-thickness burn wounds. METHODS The study was conducted with 20 New Zealand rabbits, and burn wounds were created by a brass probe. The animals were randomly divided into two groups. The burns were treated with zinc oxide (Group O) or silver sulfadiazine (Group S) with daily application. The wound healing process was followed both clinically and histopathologically. We determined the days at which 50% and 80% re-epithelization was observed. RESULTS The mean time for 50% and 80% re-epithelization was 21.4 and 25.4 days in Group O and 25.8 and 30.2 days in Group S, respectively (p<0.001). The mean score for wound colonization was lower in Group O. The difference was statistically significant at weeks 2, 3, 4, and 6 (p<0.001). In the histopathological examination, the thicknesses of the epidermis, dermis and scar tissue were 0.12 mm, 3.80 mm and 244 mm in Group O, and 0.16 mm, 4.76 mm and 3.16 mm in Group S, respectively (p<0.001). CONCLUSION In this experimental burn study, zinc oxide was more effective than silver sulfadiazine in terms of epithelization, dermis maturation and scar formation.

Özet

AMAÇ Bu çalışmada, yanık yaralarında yaygın olarak kullanılan çinko oksit ve gümüş sülfadiazinin tedavi etkileri karşılaştırıldı. GEREÇ VE YÖNTEM Yeni Zelanda cinsi 20 tavşanda pirinç propla yanık yarası oluşturuldu. Tavşanlar rastgele iki gruba ayrıldı. Yanıklar günlük uygulamayla birinci grupta çinko oksitle (Grup O), ikinci grupta (Grup S) gümüş sülfadiazinle tedavi edildi. Yara iyileşmesi klinik ve histopatolojik olarak takip edildi. Yara ölçümleri yapıldı ve %50 ve %80 reepitelizasyona ulaştığı günler belirlendi. BULGULAR Ortalama %50 ve %80 reepitelizasyona ulaşma süreleri Grup O’da sırasıyla 21,4 ve 25,4 gün, Grup S’de 25,8 ve 30,2 gündü (p<0,001). Yara kolonizasyonu ise 1, 2, 3, 4, 5 ve 6. haftalarda ortalama olarak Grup O’da daha düşüktü. Fark 2, 3, 4 ve 6. haftalarda anlamlı idi (p<0,001). Histopatolojik değerlendirme sonucunda Grup O’da epidermis, dermis ve skar dokusunun kalınlıkları sırasıyla 0,12, 3,80 ve 2,44 mm idi. Grup S’de ise 0,16, 4,76 ve 3,16 mm olarak bulundu (p<0,001). SONUÇ Bu deneysel çalışmada, çinko oksit yanık tedavisinde epitelizasyon, epidermis maturasyonu ve skar oluşumunda gümüş sülfadiazinden daha etkili bulunmuştur.

🔖

Cite This Article

ARSLAN, K., KARAHAN, Ö., OKUŞ, A., ÜNLÜ, Y., ERYILMAZ, M. A., AY, A. S., SEVİNÇ, B. (2012). Yanık yarası tedavisinde topikal çinko oksit ile gümüş sülfadiazinin karşılaştırılması: Deneysel çalışma. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 18 - Sayı: 5, 376–383. https://ajindex.com/articles/322401

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Papini RP, Wilson AP, Steer JA, McGrouther DA, Parkhouse N. Wound management in burn centres in the United King- dom. Br J Surg 1995;82:505-9
  2. Vloemans AF, Soesman AM, Suijker M, Kreis RW, Mid- delkoop E. A randomised clinical trial comparing a hydro- colloid-derived dressing and glycerol preserved allograft skin in the management of partial thickness burns. Burns 2003;29:702-10
  3. Gilman & Goodman. Pharmacologic basis of therapeutics. 5th ed. New York: McMullin; 1975. p. 930
  4. Warriner R, Burrell R. Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 2005;18:2-12
  5. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007;33:139-48
  6. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloprotein- ases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-51
  7. Demling RH, Leslie DeSanti MD. The rate of re-epitheliali- zation across meshed skin grafts is increased with exposure to silver. Burns 2002;28:264-6
  8. Lansdown AB. Silver. 2: Toxicity in mammals and how its products aid wound repair. J Wound Care 2002;11:173-7
  9. Maghsoudi H, Monshizadeh S, Mesgari M. A compara- tive study of the burn wound healing properties of saline- soaked dressing and silver sulfadiazine in rats. Indian J Surg 2011;73:24-7
  10. Khorasani G, Hosseinimehr SJ, Azadbakht M, Zamani A, Mahdavi MR. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study. Surg Today 2009;39:587-91
  11. Cho Lee AR, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 2005;26:4670-6
  12. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004;30:140-7
  13. Hollinger MA. Toxicological aspects of topical silver phar- maceuticals. Crit Rev Toxicol 1996;26:255-60
  14. Sawhney CP, Sharma RK, Rao KR, Kaushish R. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. Burns 1989;15:403-6
  15. Sheridan RL, Petras L, Lydon M, Salvo PM. Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil 1997;18:139-40
  16. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26:131-8
  17. Dickinson